(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Purity ≥98.0% (HPLC) Rivaroxaban Intermediate Factory

Chemical Name: (S)-(+)-Glycidyl Phthalimide  CAS: 161596-47-0 Appearance: White to Off-White Powder Purity: ≥98.0% (HPLC)  Intermediate of Rivaroxaban (CAS: 366789-02-8) in the treatment of Venous Thromboembolism (VTE)  Inquiry: alvin@ruifuchem.com

Products Details

Chemical Properties:

Manufacturer Supply Rivaroxaban Related Intermediates: (S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0 Rivaroxaban Intermediate CAS 446292-07-5 5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6 5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9 Rivaroxaban API CAS 366789-02-8
Item Specifications
Appearance White to Off-White Powder
Identification HPLC
Loss on Drying ≤0.50%
Sulphate Ash ≤0.50%
Purity / Analysis Method ≥98.0% (HPLC)
Phthalimide ≤0.10%
Single Max Impurity ≤0.50%
Total Impurities ≤2.0%
Epichlorohydrin ≤0.10%
Glycidol ≤0.10%
Chiral Purity R-isomer ≤2.0% (HPLC)
Test Standard Enterprise Standard
Usage Rivaroxaban (CAS: 366789-02-8) Intermediate 
(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Synthesis Route(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0

Description:

Specifications:

Package & Storage:

Chemical Name (S)-(+)-Glycidyl Phthalimide
Synonyms (S)-Glycidyl Phthalimide; (S)-N-Glycidylphthalimide; Rivaroxaban Intermediate 
CAS Number 161596-47-0
CAT Number RF-PI128
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C11H9NO3
Molecular Weight 203.19
Melting Point 102℃
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) with high quality. It is an intermediate typically in the synthesis of Rivaroxaban (CAS: 366789-02-8), in the treatment of Venous Thromboembolism (VTE).  Rivaroxaban (Xarelto; CAS: 366789-02-8) is an antithrombotic drug and was developed in a collaboration between the German Bayer Pharmaceuticals and American Johnson company. Rivaroxaban is indicated for the treatment of deep vein thrombosis and pulmonary embolism, and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours